Phase I dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of an inhaled recombinant human ACE2. - Bauer M; Jorda A; Al-Jalali V; Wölfl-Duchek M; Bergmann F; Nussbaumer-Pröll A; Steindl A; Gugenberger R; Bischof S; Wimmer D; Idzko M; Zeitlinger M (ERJ open research, 2024)